The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 34
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte TSE WEN CHANG
__________
Appeal No. 2001-2497
Application No. 08/855,744
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, SCHENER, and GRIMES, Administrative Patent
Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 1 and 3, all of the claims in the application. Claim 1 and 3
read as follows:
1. A method of enhancing delivery of a therapeutic agent selected
from the group consisting of tumor necrosis factor and interleukin-1
to a solid tissue site, comprising:
administering to a patient a conjugate consisting of two individual
single chain VH-VL binding molecules which are conjugated with a
hydrophilic peptide linker, one single chain binding molecule having
specificity for a solid tissue antigen and the other for the therapeutic
agent, and waiting until the conjugate concentration in the
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007